Definium Therapeutics Inc. Gains 49.8%
Mon, Jun 22, 2026 at 07:36 PM
Definium Therapeutics Inc. (DFTX:NASDAQ) shot up at $36.67, representing a gain of 49.8%. On Mon, Jun 22, 2026, DFTX:NASDAQ hit a New 2-Week High of $36.67. The stock got featured on our News Catalysts scanner on Mon, Jun 22, 2026 at 06:40 PM in the 'PUBLIC OFFERING' category. From Mon, Jun 08, 2026, the stock recorded 77.78% Up Days and 50.00% Green Days
About Definium Therapeutics Inc. (DFTX:NASDAQ)
The mission of Definium Therapeutics is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.
Top 10 Gainers:
- Nexentis Technologies Inc Com Par $0.0001 (New) 2025 (NXTS:NASDAQ), 155.91%
- Eshallgo Inc. (EHGO:NASDAQ), 125.56%
- Aditxt, Inc. (ADTX:NASDAQ), 92%
- Getty Images Holdings, Inc. (GETY:NYSE), 90.05%
- Tenon Medical, Inc. (TNON:NASDAQ), 77.57%
- Sky Quarry Inc. (SKYQ:NASDAQ), 62.39%
- Definium Therapeutics Inc. (DFTX:NASDAQ), 49.8%
- Conduit Pharmaceuticals Inc. (CDT:NASDAQ), 47.06%
- Apogee Therapeutics, Inc. (APGE:NASDAQ), 46.66%
- FG Merger II Corp. (FGMC:NASDAQ), 44.56%